Effectiveness of prophylactic levosimendan in high-risk valve surgery patients

Cardiovascular Journal of Africa

Volumn 24, Issue 7, 2013, Pages 260-264

  Ersoy, Ozgur ^a   Boysan, Emre ^a   Unal, Ertekin Utku ^a   Yay, Kerem ^a   Yener, Umit ^a   Cicekcioglu, Ferit ^a   Katircioglu, Fehmi ^b  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b ANKARA NUMUNE HOSPITAL   (Turkey)

Author keywords

Cardiac surgery; Cardiac valve; Left ventricular dysfunction; Levosimendan; Pulmonary hypertension

Indexed keywords

ATRACURIUM BESILATE; CARDIOPLEGIC AGENT; INOTROPIC AGENT; LEVOSIMENDAN; MIDAZOLAM; OXYGEN; PANCURONIUM; SEVOFLURANE; SUFENTANIL;

ADULT; ANESTHESIA INDUCTION; AORTA CLAMPING; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; BODY SURFACE; CARDIOPULMONARY BYPASS; CARDIOPULMONARY HEMODYNAMICS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; ENDOTRACHEAL INTUBATION; FEMALE; FUNCTIONAL STATUS; GENERAL ANESTHESIA; HEART CATHETER; HEART EJECTION FRACTION; HEART INDEX; HEART OUTPUT; HEART PROTECTION; HEART VALVE SURGERY; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LOADING DRUG DOSE; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; MORBIDITY; NEW YORK HEART ASSOCIATION CLASS; OPERATION DURATION; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROSTHETIC VALVE DYSFUNCTION; PULMONARY HYPERTENSION; SURGICAL MORTALITY; SURGICAL PATIENT; SYSTEMIC VASCULAR RESISTANCE; SYSTOLIC BLOOD PRESSURE; THERMODILUTION; THERMODILUTION DEVICE;

ARTERIAL PRESSURE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR AGENTS; DRUG ADMINISTRATION SCHEDULE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; HYDRAZONES; HYPERTENSION, PULMONARY; INFUSIONS, PARENTERAL; PULMONARY ARTERY; PYRIDAZINES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; TURKEY; VASCULAR RESISTANCE;

EID: 84889246150     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2013-047     Document Type: Article

References (16)

1. Cevese PG, Gallucci V, Valfre C, et al. Pulmonary hypertension in mitral valve surgery. J Cardiovasc Surg (Torino) 1980; 21: 7-10. (Pubitemid 10099732)
2. Vincens JJ, Temizer D, Post JR, et al. Long-term outcome of cardiac surgery in patients with mitral stenosis and severe pulmonary hypertension. Circulation 1995; 92: II137-142.
3. Figgit DP, Gillies PS, Goa KL. Levosimendan. Drugs 2001; 61: 613-627. (Pubitemid 32454527)
4. De Hert SG, Lorsomradee S, Cromheecke S, et al. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth Analg 2007; 104: 766-773. (Pubitemid 46548294)
5. Toller WG, Stranz C. Levosimendan, a new inotropic and vasodilator agent. Anesthesiology 2006; 104: 556-569.
6. Raja SG, Rayen BS. Levosimendan in cardiac surgery: current best available evidence. Ann Thorac Surg 2006; 81: 1536-1546.
7. Mebazaa A, Barraud D, Welschbillig S. Randomized clinical trials with levosimendan. Am J Cardiol 2005; 96: 74G-79G. (Pubitemid 41338077)
8. Gheorghiade M, Teerlink JR, Mebazaa A. Pharmacology of new agents for acute heart failure syndromes. Am J Cardiol 2005; 96: 68G-73G. (Pubitemid 41338076)
9. McBride BF, White CM. Levosimendan: implications for clinicians. J Clin Pharmacol 2003; 43: 1071-1081. (Pubitemid 37174438)
10. Tritapepe L, De Santis V, Vitale D, et al. Preconditioning effects of levosimendan in coronary artery bypass grafting - a pilot study. Br J Anaesth 2006; 96: 694-700. (Pubitemid 43786683)
11. Leppikangas H, Järvelä K, Sisto T, et al. Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery. Br J Anaesth 2011; 106: 298-304.
12. Brezina A, Riha H, Pirk J. Prophylactic application of levosimendan in cardiac surgical patients with severe left ventricle dysfunction. Exp Clin Cardiol 2009; 14: e31-34.
13. Tritapepe L, De Santis V, Vitale D, et al. Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br J Anaesth 2009; 102: 198-204.
14. Follath F, Franco F, Cardoso JS. European experience on the practical use of levosimendan in patients with acute heart failure syndromes. Am J Cardiol 2005; 96: 80G-85G. (Pubitemid 41338078)
15. Tachibana H, Cheng HJ, Ukai T, et al. Levosimendan improves LV systolic and diastolic performance at rest and during exercise after heart failure. Am J Physiol Heart Circ Physiol 2005; 288: H914-922. (Pubitemid 40139680)
16. Lilleberg J, Nieminen MS, Akkila J, et al. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J 1998; 19: 660-668. (Pubitemid 28224690)